Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

NCT02225912 is registered in ClinicalTrials.gov with BioHealth Technologies Inc. as lead sponsor.

NCT NCT02225912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02225912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers
Lead sponsor
BioHealth Technologies Inc.
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2005
Completion date
May 31, 2005
Enrollment
Not reported
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

upper respiratory infections